Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Cell Therapy Asia 2018

Hiromitsu Nakauchi's Biography



Hiromitsu Nakauchi, Prof of Genetics, Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine Project Professor, The Institute of Medical Science, Division of Stem Cell Therapy, Distinguished Professor Unit, The University of Tokyo

After earning M.D. and a Ph.D. in Japan, Dr. Nakauchi went to Stanford University as a postdoctoral scholar and isolated CD8 genes. After returning to Japan, he started working on hematopoietic stem cells in his laboratory at RIKEN. In 1994, he became a Professor of Immunology at the University of Tsukuba where he demonstrated that a single hematopoietic stem cell could reconstitute the entire hematopoietic system, a definitive experimental proof for the “stemness”. Since April 2002, he has been a Professor of Stem Cell Therapy in the Institute of Medical Science at The University of Tokyo (IMSUT). In 2014, he returned to Stanford University as a faculty to continue his stem cell research at the Institute of Stem Cell Biology and Regenerative Medicine. Goals of his work are to translate discoveries in basic research into practical medical applications.

Hiromitsu Nakauchi Image

Translating Stem Cell Research: Challenges At Front Line

Thursday, 6 December 2018 at 13:00

Add to Calendar ▼2018-12-06 13:00:002018-12-06 14:00:00Europe/LondonTranslating Stem Cell Research: Challenges At Front LineCell Therapy Asia 2018 in Kobe, JapanKobe, JapanSELECTBIOenquiries@selectbiosciences.com

The recent development of induced pluripotent stem cell (iPSC) technology opened the way to regenerative medicine using a patient’s own PSC-derived cells.  In this presentation, I describe some of our iPSC technology-based projects aiming at clinical use.


Add to Calendar ▼2018-12-06 00:00:002018-12-07 00:00:00Europe/LondonCell Therapy Asia 2018Cell Therapy Asia 2018 in Kobe, JapanKobe, JapanSELECTBIOenquiries@selectbiosciences.com